Brief: Cantargia Reports New Positive Data For CAN10

Cantargia AB

25/07/2022 14:03

July 25 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA REPORTS NEW POSITIVE PRECLINICAL EFFICACY DATA
FOR
CAN10 SUPPORTING DEVELOPMENT IN MYOCARDITIS
    * RESULTS HIGHLIGHT POTENTIAL OF CAN10 IN TREATMENT OF THIS
COMMON
FORM OF MYOCARDITIS AHEAD OF PLANNED CLINICAL TRIALS.
    * ECHOCARDIOGRAPHY ALSO CONFIRMED THAT CAN10 SURROGATE
ANTIBODY
PRESERVED HEART FUNCTION. THESE EFFECTS WERE NOT ACHIEVED BY
BLOCKING IL-1 SIGNALING ALONE

Source text for Eikon:  ID:nWkr1wDRt5 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))